Gurgaon Samachar

Breast Cancer Screening Market, Global Forecast by Screening Test, Population, Countries, Company Analysis

 Breaking News
  • No posts were found

Breast Cancer Screening Market, Global Forecast by Screening Test, Population, Countries, Company Analysis

April 28
18:45 2020
Breast Cancer Screening Market, Global Forecast by Screening Test, Population, Countries, Company Analysis

Global Breast Cancer Screening Market is anticipated to reach US$ 51.8 Billion by the end of the year 2026,
According to Renub Research analysis Global Breast Cancer Screening Market will be US$ 51.8 Billion by 2026. Forecast by Population & Screening Tests

Globally, breast cancer is considered one of the most common cancers in women around the world. Breast cancer is also a leading cause of death from cancer in the world’s least developed nations. Every year 1.7 Million new cases are diagnosed with breast cancer, and approximately 60% of deaths due to breast cancer occur around the world. Breast cancer is a form of cancer that occurs in the tissue of the breast. Formations of a lump in a breast and red patches on the skin are some of the typical breast cancer signs. Obesity, lack of physical activity, overexposure to radiation, and consuming alcohol are among the risk factors for breast cancer growth. According to Renub Research report, the Global Breast Cancer Screening Market is anticipated to reach US$ 51.8 Billion by the end of the year 2026, with double-digit CAGR during the forecast period.

 

COVID – 19 impact on Breast Cancer Screening Market Worldwide

The COVID-19 outbreak could have an impact on all drug companies manufacturing, supply chain, and clinical trial operations. In the year 2020, the global breast cancer screening population, as well as the market, will decline. The primary reason for this decline is a coronavirus. For a complete analysis, read our report as to how COVID – 19 is affecting every quarter of the year 2020 and when the market will revive? Other challenges of breast cancer screening are high medication costs, therapy-related adverse effects, and lengthy product approval times are responsible for curbing market growth.

 

 

Growth Factors for Global Breast Cancer Screening Market

The key growth factors of the breast cancer market are the increasing number of females suffering from breast cancer, growing older women population is the primary factor for the growth of the market. In addition to this adoption of an unhealthy lifestyle, the rise of the female geriatric population, exposure to harmful radiation, and increased policy measures have contributed to market growth.

 

Also, the incidence of breast cancer is rising in the lower-income countries due to an increase in life expectancy, adaption to increasing urbanization and western lifestyles. World over, more than half of the breast cancer cases now have been reported from low and middle-income countries (LMICs) as these countries do not have proper breast screening programs; hence, the majority of cases are diagnosed in late stages. Growing breast cancer incidences & mortality in the low and middle-income countries, these countries need to develop an effective breast cancer screening program strategy that will address the earlier deduction of incidence of breast cancer for women.

 

Some of the major breast cancer screening technologies which help to find breast cancer after diagnosis are as follows. Breast cancer screening technologies are MRI, Ultrasound, and mammography screening. Mammography screening aims at minimizing the death rate from breast cancer by identifying unsuspected breast cancers early. The breast cancer mammography screening market is flourishing, driven by advances in technologies and delivery models, product innovations, increasing use of digital mammography equipment, and growing public awareness. Globally, awareness about breast cancer is increasing, with more women coming forward for their yearly mammograms after the age of 40 years.

 

Besides, around the world, governments have introduced screening programs for early detection that entails a routine check-up. Several countries are already offering breast cancer screening programs for women, and the number is establishing these programs are steadily increasing. In Germany, for example, the “Mammo Screening” program exists since 2002. In the United States, most states are introducing laws requiring health insurance companies to reimburse all or part of the cost of screening mammograms. Furthermore, the NHS Breast Screening Program in the United Kingdom provides free breast screening every three years for all women aged. Also, continuous efforts are taken by various government agencies and NGOs, the worldwide market for breast cancer screening.

Renub Research latest study report “Breast Cancer Screening Market, Population, By Screening Tests [Mammography, Magnetic Resonance Imaging (MRI) & Ultrasound] Countries (United States, Canada, France, United Kingdom, Germany, Italy, Spain, Netherlands, Norway, Switzerland, China, India, Korea, Japan, Singapore, Thailand, Malaysia, Brazil, Australia, New Zealand, South Africa, United Arab Emirates, Saudi Arabia), Company Analysis (AstraZeneca, Novartis, Sanofi, Pfizer, Bayer AG)” provides a detailed and comprehensive insight of the Breast Cancer Screening Market.

 

Screening Tests – Mammography is the Most Common Test for Breast Cancer Screening

Mammography is a sophisticated medical imaging that uses a low-dose x-ray device to view human breasts indoors. Mammography plays a vital role in the early detection and treatment of women with breast diseases. Breast Magnetic Resonance Imaging (MRI) or breast ultrasound, in addition to mammography, also helps detect breast cancer in women.

 

Countries – Total 23 Countries Market & Population for Breast Cancer Screening, Mammography Screening, MRI Screening & Ultrasound Screening has been studied in the report

The study includes a comprehensive Breast cancer overview of Canada, France, Italy, Spain, Switzerland, Netherlands, Norway, India, Australia, Japan, Korea, Singapore, Thailand, Malaysia, Brazil, New Zealand, South Africa, United Arab Emirates and Saudi Arabia Breast Cancer, Mammography, Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population and Market.

 

Request a free Brochure copy of the report: https://www.renub.com/request-sample-page.php?gturl=breast-cancer-screening-mammography-mri-and-ultrasound-market-and-forecast-worldwide-63-p.php

 

The report provides a complete analysis of the key Growth Drivers, Challenges, Market, Screened Population, and their projections for the upcoming years till 2026.

All the companies have been studied from two points

    • Recent Developments
    • Sales Analysis

Company Analysis

    • AstraZeneca
    • Novartis
    • Sanofi
    • Pfizer
    • Bayer AG

Breast Cancer Screening Market & Population – By Screening Tests Covered in the Report

    • Mammography
    • Magnetic Resonance Imaging (MRI)
    • Ultrasound

23 Regions Covered in the Report

    1. United States
    2. Canada
    3. United Kingdom
    4. France
    5. Germany
    6. Italy
    7. Spain
    8. Netherlands
    9. Norway
    10. Switzerland
    11. India
    12. China
    13. Japan
    14. Korea
    15. Singapore
    16. Thailand
    17. Malaysia
    18. Brazil
    19. Australia
    20. New Zealand
    21. South Africa
    22. United Arab Emirates
    23. Saudi Arabia

Renub Research Analysis Blog: https://renubresearch.wixsite.com/report/blog

If the information you seek is not included in the current scope of the study kindly share your specific requirements with our custom research team.

Browse Related Report :

Molecular Diagnostics Market

United States Biopsy Market

Contact Us

Renub Research
Phone:+1-678-302-0700
Email: [email protected]

Key Topics Covered:

1. Introduction
2. Research & Methodology
3. Executive Summary

4. Global Breast Cancer Screening Population

    4.1 Mammography Screening Population
    4.2 MRI & Ultrasound Screening Population

5. Global Breast Cancer Screening Market

    5.1 Mammography Screening Market
    5.2 Magnetic Resonance Imaging (MRI) Screening Market
    5.3 Ultrasound Screening Market

6. Population Share – Global Breast Cancer Screening

    6.1 Breast Cancer Screening
    6.2 Mammography Screening
    6.3 MRI & Ultrasound Screening

7. Market Share – Global Breast Cancer Screening

    7.1 Breast Cancer Screening
    7.2 Mammography Screening
    7.3 MRI Screening
    7.4 Ultrasound Screening

8. United Kingdom – Breast Cancer Screening Population & Market

    8.1 United Kingdom Breast Cancer Screening Population & Forecast
    8.2 United Kingdom Breast Cancer Screening Market & Forecast

 
9. France – Breast Cancer Screening Population & Market

    9.1 France Breast Cancer Screening Population & Forecast
    9.2 France Breast Cancer Screening Market & Forecast

10. Germany – Breast Cancer Screening Population & Market

    10.1 Germany Breast Cancer Screening Population & Forecast
    10.2 Germany Breast Cancer Screening Market & Forecast

 
11. Italy – Breast Cancer Screening Population & Market

    11.1 Italy Breast Cancer Screening Population & Forecast
    11.2 Italy Breast Cancer Screening Market & Forecast

12. Spain – Breast Cancer Screening Population & Market

    12.1 Spain Breast Cancer Screening Population & Forecast
    12.2 Spain Breast Cancer Screening Market & Forecast

13. Switzerland – Breast Cancer Screening Population & Market

    13.1 Switzerland Breast Cancer Screening Population & Forecast
    13.2 Switzerland Breast Cancer Screening Market & Forecast

14. Norway – Breast Cancer Screening Population & Market

    14.1 Norway Breast Cancer Screening Population & Forecast
    14.2 Norway Breast Cancer Screening Market & Forecast

15. Netherlands – Breast Cancer Screening Population & Market

    15.1 Netherlands Breast Cancer Screening Population & Forecast
    15.2 Netherlands Breast Cancer Screening Market & Forecast

16. United States – Breast Cancer Screening Population & Market

    16.1 United States Breast Cancer Screening Population & Forecast
    16.2 United States Breast Cancer Screening Market & Forecast

17. Canada – Breast Cancer Screening Population & Market

    17.1 Canada Breast Cancer Screening Population & Forecast
    17.2 Canada Breast Cancer Screening Market & Forecast

18. Japan – Breast Cancer Screening Population & Market

    18.1 Japan Breast Cancer Screening Population & Forecast
    18.2 Japan Breast Cancer Screening Market & Forecast

19. Korea – Breast Cancer Screening Population & Market

    19.1 Korea Breast Cancer Screening Population & Forecast
    19.2 Korea Breast Cancer Screening Market & Forecast

20. Singapore – Breast Cancer Screening Population & Market

    20.1 Singapore Breast Cancer Screening Population & Forecast
    20.2 Singapore Breast Cancer Screening Market & Forecast

21. Malaysia – Breast Cancer Screening Population & Market

    21.1 Malaysia Breast Cancer Screening Population & Forecast
    21.2 Malaysia Breast Cancer Screening Market & Forecast

22. India – Breast Cancer Screening Population & Market

    22.1 India Breast Cancer Screening Population & Forecast
    22.2 India Breast Cancer Screening Market & Forecast

23. China – Breast Cancer Screening Population & Market

    23.1 China Breast Cancer Screening Population & Forecast
    23.2 China Breast Cancer Screening Market & Forecast

24. Thailand – Breast Cancer Screening Population & Market

    24.1 Thailand Breast Cancer Screening Population & Forecast
    24.2 Thailand Breast Cancer Screening Market & Forecast

25. Brazil – Breast Cancer Screening Population & Market

    25.1 Brazil Breast Cancer Screening Population & Forecast
    25.2 Brazil Breast Cancer Screening Market & Forecast

26. Australia – Breast Cancer Screening Population & Market

    26.1 Australia Breast Cancer Screening Population & Forecast
    26.2 Australia Breast Cancer Screening Market & Forecast

27. New Zealand – Breast Cancer Screening Population & Market

    27.1 New Zealand Breast Cancer Screening Population & Forecast
    27.2 New Zealand Breast Cancer Screening Market & Forecast

28. South Africa – Breast Cancer Screening Population & Market

    28.1 South Africa Breast Cancer Screening Population & Forecast
    28.2 South Africa Breast Cancer Screening Market & Forecast

29. United Arab Emirates – Breast Cancer Screening Population & Market

    29.1 United Arab Emirates Breast Cancer Screening Population & Forecast
    29.2 United Arab Emirates Breast Cancer Screening Market & Forecast

30. Saudi Arabia – Breast Cancer Screening Population & Market

    30.1 Saudi Arabia Breast Cancer Screening Population & Forecast
    30.2 Saudi Arabia Breast Cancer Screening Market & Forecast

31. Growth Drivers

    31.1 Increasing Women’s Breast Cancer Care
    31.2 Growing Breast Cancer Cases
    31.3 Reclassification of Mammography Equipment by FDA

32. Breast Cancer Screening Market Challenges

    32.1 Difference of Opinion on Breast Cancer Mammography Screening
    32.2 Societal and Cultural Barriers for Breast Cancer Screening

33. Company Analysis

    33.1 AstraZeneca
    33.2 Novartis
    33.3 Sanofi
    33.4 Pfizer
    33.5 Bayer AG

About Us:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys, and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. Our clients rely on our market analysis and data to make informed knowledgeable decisions. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.

Media Contact
Company Name: Renub Research
Contact Person: Rajat Gupta
Email: Send Email
Phone: 16783020700
Address:225 Kristie Ln
City: Roswell
State: GA
Country: United States
Website: https://www.renub.com/diagnostics-14-c.php


Warning: count(): Parameter must be an array or an object that implements Countable in /home/haridwartoday/gurgaon-samachar.com/wp-content/themes/legatus-theme/includes/single/post-tags.php on line 5
Share